New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
COVID infection may boost antibodies for up to 20 months

COVID infection may boost antibodies for up to 20 months

If you've already had COVID-19, your natural antibodies may last as long as 20 months, a new study suggests.While this is reassuring, experts are quick to caution that the new findings don't n
Immunology & Rheumatology April 13,2024
COVID infection may boost antibodies for up to 20 months

COVID infection may boost antibodies for up to 20 months

If you've already had COVID-19, your natural antibodies may last as long as 20 months, a new study suggests.While this is reassuring, experts are quick to caution that the new findings don't n
Immunology & Rheumatology April 13,2024
A COVID-19 biomarker: Low blood levels of sphingosine predict symptomatic infections

A COVID-19 biomarker: Low blood levels of sphingosine predict symptomatic infections

by Medical University of South CarolinaImage of the ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV). Credit: CDCResearchers remain perplexed as to why some patients
Immunology & Rheumatology April 13,2024
A COVID-19 biomarker: Low blood levels of sphingosine predict symptomatic infections

A COVID-19 biomarker: Low blood levels of sphingosine predict symptomatic infections

by Medical University of South CarolinaImage of the ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV). Credit: CDCResearchers remain perplexed as to why some patients
Immunology & Rheumatology April 13,2024
CRISPR screen reveals loss of genes in interferon gamma receptor signaling pathway

CRISPR screen reveals loss of genes in interferon gamma receptor signaling pathway

by Massachusetts General HospitalGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers at Massachusetts General Hospital (MGH) have discovered that the interferon gamma recept
Immunology & Rheumatology April 13,2024
CRISPR screen reveals loss of genes in interferon gamma receptor signaling pathway

CRISPR screen reveals loss of genes in interferon gamma receptor signaling pathway

by Massachusetts General HospitalGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers at Massachusetts General Hospital (MGH) have discovered that the interferon gamma recept
Immunology & Rheumatology April 13,2024
C-reactive protein reduces the immune response in inflammatory disease

C-reactive protein reduces the immune response in inflammatory disease

by Karin Söderlund Leifler,Linköping UniversityGraphical abstract. Credit:Journal of Autoimmunity(2023). DOI: 10.1016/j.jaut.2023.102998The biological function of the C-reactive prot
Immunology & Rheumatology April 13,2024
C-reactive protein reduces the immune response in inflammatory disease

C-reactive protein reduces the immune response in inflammatory disease

by Karin Söderlund Leifler,Linköping UniversityGraphical abstract. Credit:Journal of Autoimmunity(2023). DOI: 10.1016/j.jaut.2023.102998The biological function of the C-reactive prot
Immunology & Rheumatology April 13,2024
COVID booster vaccines: How a third dose may help vulnerable people 'level up' their immunity

COVID booster vaccines: How a third dose may help vulnerable people 'level up' their immunity

by Nathan Cheetham,The ConversationCredit: Unsplash/CC0 Public DomainCOVID vaccines call our immune systems to action, generating antibodies which fight against any contact we have with the viru
Immunology & Rheumatology April 13,2024
COVID booster vaccines: How a third dose may help vulnerable people 'level up' their immunity

COVID booster vaccines: How a third dose may help vulnerable people 'level up' their immunity

by Nathan Cheetham,The ConversationCredit: Unsplash/CC0 Public DomainCOVID vaccines call our immune systems to action, generating antibodies which fight against any contact we have with the viru
Immunology & Rheumatology April 13,2024
COVID: On the lookout for new antibodies

COVID: On the lookout for new antibodies

by Friedrich–Alexander University Erlangen–NurnbergCredit: Pixabay/CC0 Public DomainA team of researchers at FAU and Universitätsklinikum Erlangen has gained new insights into the maturation of S
Immunology & Rheumatology April 13,2024
COVID: On the lookout for new antibodies

COVID: On the lookout for new antibodies

by Friedrich–Alexander University Erlangen–NurnbergCredit: Pixabay/CC0 Public DomainA team of researchers at FAU and Universitätsklinikum Erlangen has gained new insights into the maturation of S
Immunology & Rheumatology April 13,2024
CRISPR study reveals new immune system regulators

CRISPR study reveals new immune system regulators

by Wellcome Trust Sanger InstituteCRISPR-associated protein Cas9 (white) from Staphylococcus aureus based on Protein Database ID 5AXW. Credit: Thomas Splettstoesser (Wikipedia, CC BY-SA 4.0)Scien
Immunology & Rheumatology April 13,2024
CRISPR study reveals new immune system regulators

CRISPR study reveals new immune system regulators

by Wellcome Trust Sanger InstituteCRISPR-associated protein Cas9 (white) from Staphylococcus aureus based on Protein Database ID 5AXW. Credit: Thomas Splettstoesser (Wikipedia, CC BY-SA 4.0)Scien
Immunology & Rheumatology April 13,2024
COVID-19 vaccines produce antibody response in the nasal mucosa

COVID-19 vaccines produce antibody response in the nasal mucosa

by University of North Carolina Health CarePre-immunity and post-immunity SARS-CoV-2 virus-specific IgG and IgA antibody concentrations in NELF and serum. Antibody concentrations were reported as
Immunology & Rheumatology April 13,2024
COVID-19 vaccines produce antibody response in the nasal mucosa

COVID-19 vaccines produce antibody response in the nasal mucosa

by University of North Carolina Health CarePre-immunity and post-immunity SARS-CoV-2 virus-specific IgG and IgA antibody concentrations in NELF and serum. Antibody concentrations were reported as
Immunology & Rheumatology April 13,2024
Does COVID really damage your immune system and make you more vulnerable to infections? The evidence is lacking

Does COVID really damage your immune system and make you more vulnerable to infections? The evidence is lacking

by Sheena Cruickshank,The ConversationCredit: AI-generated imageOver the past month or two, manynorthern hemisphere countriesincluding the U.S. and the U.K. have seen a large wave of
Immunology & Rheumatology April 13,2024
Does COVID really damage your immune system and make you more vulnerable to infections? The evidence is lacking

Does COVID really damage your immune system and make you more vulnerable to infections? The evidence is lacking

by Sheena Cruickshank,The ConversationCredit: AI-generated imageOver the past month or two, manynorthern hemisphere countriesincluding the U.S. and the U.K. have seen a large wave of
Immunology & Rheumatology April 13,2024
CRP levels potentially useful in chronic spontaneous urticaria

CRP levels potentially useful in chronic spontaneous urticaria

(HealthDay)—C-reactive protein (CRP) levels are frequently elevated in patients with chronic spontaneous urticaria (CSU), and these elevations are relevant and potentially useful in management of the
Immunology & Rheumatology April 13,2024
CRP levels potentially useful in chronic spontaneous urticaria

CRP levels potentially useful in chronic spontaneous urticaria

(HealthDay)—C-reactive protein (CRP) levels are frequently elevated in patients with chronic spontaneous urticaria (CSU), and these elevations are relevant and potentially useful in management of the
Immunology & Rheumatology April 13,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com